In particular, numerous aptamers have been established targeting cancer-specific signature markers such as immunosuppressive programmed cell death protein 1 (PD-1), immunosuppressive CD137, CD134, tumor-forming platelet-derived growth factor, and vascular endothelial growth factor [26]. This evidence concerns the gene PDCD1 and cancer.